Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL2991019

O=C(O)c1c2ccccc2nc2ccccc12.O=S(=O)(O)C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.50
DHODH Q02127 5/20 0.47
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.46
KMT2A Q03164 4/20 0.46
ALDH1A1 P00352 4/20 0.46
MEN1 O00255 3/20 0.46
KDM4E B2RXH2 3/20 0.46
CYP2C19 P33261 2/20 0.46
GLA P06280 2/20 0.46
HPGD P15428 2/20 0.46
CYP1A2 P05177 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CYP2D6 P10635 1/20 0.43
GAA P10253 1/20 0.41
ATM Q13315 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CDC7 O00311 1/20 0.40
EEF2K O00418 1/20 0.40
PLK4 O00444 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL2991025 1.00 PDE10A (0.50) PDE10ADHODHLMNATSHRKMT2A
SCHEMBL9056825 0.88 PDE10A (0.54) PDE10ADHODHLMNATSHRKMT2A
SCHEMBL9056820 0.88 PDE10A (0.54) PDE10ADHODHLMNATSHRKMT2A
SCHEMBL641899 0.84 PDE10A (0.66) PDE10ADHODHLMNATSHRKMT2A
SCHEMBL29377848 0.84 PDE10A (0.66) PDE10ADHODHLMNATSHRKMT2A
Trifluoromethanesulfonic Acid SCHEMBL6014201 0.83 MEN1 (0.56) PDE10ADHODHKMT2AALDH1A1MEN1
Hydrochloric Acid SCHEMBL1603404 0.82 PDE10A (0.63) PDE10ADHODHLMNATSHRKMT2A
Iodide SCHEMBL8029606 0.82 PDE10A (0.63) PDE10ADHODHLMNATSHRKMT2A
Phenazine SCHEMBL30542151 0.82 MAPT (0.50) KMT2AALDH1A1MEN1KDM4EGLA
Iodide SCHEMBL8029601 0.82 PDE10A (0.63) PDE10ADHODHLMNATSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9533974-B2 Ultra-sensitive chemiluminescent substrates for enzymes and their conjugates MICHIGAN DIAGNOSTICS, LLC (US) 2017-01-03 US disclosed
US-20150031889-A1 ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR ENZYMES AND THEIR CONJUGATES GIRI BRIJ PAL (US) 2015-01-29 US disclosed
US-8932881-B2 Ultra-sensitive chemiluminescent substrates for enzymes and their conjugates GIRI BRIJ PAL (US) 2015-01-13 US disclosed
US-20140088297-A1 NEW ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR ENZYMES AND THEIR CONJUGATES MICHIGAN DIAGNOSTICS, LLC (US) 2014-03-27 US disclosed
US-20140073771-A1 NEW ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR ENZYMES AND THEIR CONJUGATES MICHIGAN DIAGNOSTICS, LLC (US) 2014-03-13 US disclosed
US-7781229-B2 water-soluble, stable in aqueous buffers, for use in biological assaying include acridane-based compounds and (1,2)-dioxetanes; used in the detection of antibodies or antigen in biological fluids and for compounds, particularly toxins and contaminants in the environment and food. MICHIGAN DIAGNOSTICS, LLC (US) 2010-08-24 US disclosed
US-20070225498-A1 water-soluble, stable in aqueous buffers, for use in biological assaying include acridane-based compounds and (1,2)-dioxetanes; used in the detection of antibodies or antigen in biological fluids and for compounds, particularly toxins and contaminants in the environment and food. MICHIGAN DIAGNOSTICS, LLC 2007-09-27 US disclosed
EP-1735621-A2 NEW ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR ENZYMES AND THEIR CONJUGATES Giri, Brij P. (US) 2006-12-27 EP disclosed
WO-2006073424-A9 NEW ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR ENZYMES AND THEIR CONJUGATES GIRI BRIJ P (US) 2006-08-24 WO disclosed
WO-2006073424-A2 NEW ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR ENZYMES AND THEIR CONJUGATES GIRI BRIJ P (US) 2006-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140088297-A1 NEW ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR ENZYMES AND THEIR CONJUGATES DUOX1, XDH, MPO PDE10A 977/4885DHODH 106/4885LMNA 2129/4885
US-20150031889-A1 ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR ENZYMES AND THEIR CONJUGATES DUOX1, XDH, MPO PDE10A 986/4885DHODH 116/4885LMNA 1938/4885
US-20070225498-A1 water-soluble, stable in aqueous buffers, for use in biological assaying include acridane-based compounds and (1,2)-dioxetanes; used in the detection of antibodies or antigen in biological fluids and for compounds, particularly toxins and contaminants in the environment and food. BTD, DDT, LPO PDE10A 1849/4885DHODH 157/4885LMNA 2310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.